Literature DB >> 15538045

Clinicopathological feature and long-term prognosis of apocrine carcinoma of the breast in Japanese women.

Hideya Takeuchi1, Kohichi Tsuji, Hiroaki Ueo, Tadashi Kano, Yoshihiko Maehara.   

Abstract

Because of the rarity of apocrine carcinoma and lack of standardized criteria for the diagnosis, the definitive conclusions of clinicopathologic features and the prognosis has not been determined. We retrospectively examined data on 2091 curatively treated Japanese patients with primary breast carcinoma. Among them, 33 (1.6%) who had been diagnosed of apocrine carcinoma were reviewed. Compared with non-apocrine carcinoma, apocrine carcinoma was characterized by less positive rates of ER and PR, and by frequent rates of unilateral multicentric breast carcinoma with significant difference. The clinicopathological factors influencing 12-year survival rate were lymph node metastasis, lymphatic involvement and vascular involvement. There was no difference in survival rates at 10 years after operation between apocrine carcinoma and non-apocrine carcinoma. Our result shows unique hormone response and unilateral multicentricity are only typical clinicopathological features of apocrine carcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15538045     DOI: 10.1007/s10549-004-9495-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

1.  Cystic apocrine ductal carcinoma in situ with increased EGFR expression, trisomy 7, and associated focal invasion.

Authors:  Shogo Tajima; Michihiko Waki; Hatsuko Nasu; Yoshimi Ide
Journal:  Med Mol Morphol       Date:  2014-11-06       Impact factor: 2.309

2.  Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database.

Authors:  Ning Zhang; Hanwen Zhang; Tong Chen; Qifeng Yang
Journal:  Oncotarget       Date:  2017-04-11

3.  Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.

Authors:  Wenyu Wu; Meiying Wu; Guowen Peng; Degang Shi; Jian Zhang
Journal:  Cancer Med       Date:  2019-10-23       Impact factor: 4.452

4.  The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer.

Authors:  Hong-Ye Liao; Wen-Wen Zhang; Jia-Yuan Sun; Feng-Yan Li; Zhen-Yu He; San-Gang Wu
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

Review 5.  Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants.

Authors:  Fresia Pareja; Felipe C Geyer; Caterina Marchiò; Kathleen A Burke; Britta Weigelt; Jorge S Reis-Filho
Journal:  NPJ Breast Cancer       Date:  2016-11-16

6.  Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy.

Authors:  Emilia Montagna; Giuseppe Cancello; Eleonora Pagan; Vincenzo Bagnardi; Elisabetta Munzone; Silvia Dellapasqua; Giuseppe Viale; Giovanni Mazzarol; Paolo Veronesi; Viviana Galimberti; Giorgia Santomauro; Marco Colleoni
Journal:  Breast       Date:  2020-07-24       Impact factor: 4.380

7.  Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis.

Authors:  Francesca Sanges; Matteo Floris; Paolo Cossu-Rocca; Maria R Muroni; Giovanna Pira; Silvana Anna Maria Urru; Renata Barrocu; Silvano Gallus; Cristina Bosetti; Maurizio D'Incalci; Alessandra Manca; Maria Gabriela Uras; Ricardo Medda; Elisabetta Sollai; Alma Murgia; Dolores Palmas; Francesco Atzori; Angelo Zinellu; Francesca Cambosu; Tiziana Moi; Massimo Ghiani; Vincenzo Marras; Maria Cristina Santona; Luisa Canu; Enrichetta Valle; Maria Giuseppina Sarobba; Daniela Onnis; Anna Asunis; Sergio Cossu; Sandra Orrù; Maria Rosaria De Miglio
Journal:  BMC Cancer       Date:  2020-06-02       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.